1223 Trax
BioCentury & Getty Images

Management Tracks

CFO transitions at Translate, Spero, Ziopharm, Precision, CASI, Tessa, Kiniksa and Aquestive; plus updates from 3T, Novavax, Alnylam and more

Dec 21, 2020 | 8:58 PM GMT

mRNA company Translate Bio Inc. (NASDAQ:TBIO) announced John Schroer will step down as CFO at year-end. VP and corporate controller Robert Prentiss will serve as principal accounting officer on an interim basis. 

Antibiotics developer Spero Therapeutics Inc. (NASDAQ:SPRO) appointed Satyavrat “Sath” Shukla as CFO, effective Jan. 4. Shukla

Read the full 777 word article

How to gain access

Continue reading with a
two-week free trial.